We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1xa5

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1xa5.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1xa5.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1xa5| PDB=1xa5 | SCENE= }}
{{STRUCTURE_1xa5| PDB=1xa5 | SCENE= }}
-
'''Structure of Calmodulin in complex with KAR-2, a bis-indol alkaloid'''
+
===Structure of Calmodulin in complex with KAR-2, a bis-indol alkaloid===
-
==Overview==
+
<!--
-
3'-(beta-Chloroethyl)-2',4'-dioxo-3,5'-spiro-oxazolidino-4-deacetoxyvinbla stine (KAR-2) is a potent anti-microtubular agent that arrests mitosis in cancer cells without significant toxic side effects. In this study we demonstrate that in addition to targeting microtubules, KAR-2 also binds calmodulin, thereby countering the antagonistic effects of trifluoperazine. To determine the basis of both properties of KAR-2, the three-dimensional structure of its complex with Ca(2+)-calmodulin has been characterized both in solution using NMR and when crystallized using x-ray diffraction. Heterocorrelation ((1)H-(15)N heteronuclear single quantum coherence) spectra of (15)N-labeled calmodulin indicate a global conformation change (closure) of the protein upon its binding to KAR-2. The crystal structure at 2.12-A resolution reveals a more complete picture; KAR-2 binds to a novel structure created by amino acid residues of both the N- and C-terminal domains of calmodulin. Although first detected by x-ray diffraction of the crystallized ternary complex, this conformational change is consistent with its solution structure as characterized by NMR spectroscopy. It is noteworthy that a similar tertiary complex forms when calmodulin binds KAR-2 as when it binds trifluoperazine, even though the two ligands contact (for the most part) different amino acid residues. These observations explain the specificity of KAR-2 as an anti-microtubular agent; the drug interacts with a novel drug binding domain on calmodulin. Consequently, KAR-2 does not prevent calmodulin from binding most of its physiological targets.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15596444}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15596444 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15596444}}
==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Kar-2]]
[[Category: Kar-2]]
[[Category: Vinca alkaloid]]
[[Category: Vinca alkaloid]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 14:46:08 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 00:09:09 2008''

Revision as of 21:09, 28 July 2008

Image:1xa5.png

Template:STRUCTURE 1xa5

Structure of Calmodulin in complex with KAR-2, a bis-indol alkaloid

Template:ABSTRACT PUBMED 15596444

About this Structure

1XA5 is a Single protein structure of sequence from Bos taurus. Full crystallographic information is available from OCA.

Reference

The structure of the complex of calmodulin with KAR-2: a novel mode of binding explains the unique pharmacology of the drug., Horvath I, Harmat V, Perczel A, Palfi V, Nyitray L, Nagy A, Hlavanda E, Naray-Szabo G, Ovadi J, J Biol Chem. 2005 Mar 4;280(9):8266-74. Epub 2004 Dec 13. PMID:15596444

Page seeded by OCA on Tue Jul 29 00:09:09 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1xa5"
Personal tools